These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 30540162)
1. Multifunctional Vector for Delivery of Genome Editing Plasmid Targeting β-Catenin to Remodulate Cancer Cell Properties. He XY; Liu BY; Peng Y; Zhuo RX; Cheng SX ACS Appl Mater Interfaces; 2019 Jan; 11(1):226-237. PubMed ID: 30540162 [TBL] [Abstract][Full Text] [Related]
2. Peptide and Aptamer Decorated Delivery System for Targeting Delivery of Cas9/sgRNA Plasmid To Mediate Antitumor Genome Editing. Liu BY; He XY; Xu C; Ren XH; Zhuo RX; Cheng SX ACS Appl Mater Interfaces; 2019 Jul; 11(27):23870-23879. PubMed ID: 31257851 [TBL] [Abstract][Full Text] [Related]
3. Aptamer/Peptide-Functionalized Genome-Editing System for Effective Immune Restoration through Reversal of PD-L1-Mediated Cancer Immunosuppression. He XY; Ren XH; Peng Y; Zhang JP; Ai SL; Liu BY; Xu C; Cheng SX Adv Mater; 2020 Apr; 32(17):e2000208. PubMed ID: 32147886 [TBL] [Abstract][Full Text] [Related]
4. Tumor targeted genome editing mediated by a multi-functional gene vector for regulating cell behaviors. Liu BY; He XY; Zhuo RX; Cheng SX J Control Release; 2018 Dec; 291():90-98. PubMed ID: 30339905 [TBL] [Abstract][Full Text] [Related]
5. A multifunctional non-viral vector for the delivery of MTH1-targeted CRISPR/Cas9 system for non-small cell lung cancer therapy. Wang Y; Tang Y; Zhao XM; Huang G; Gong JH; Yang SD; Li H; Wan WJ; Jia CH; Chen G; Zhang XN Acta Biomater; 2022 Nov; 153():481-493. PubMed ID: 36162766 [TBL] [Abstract][Full Text] [Related]
6. A Dual-Targeting Delivery System for Effective Genome Editing and In Situ Detecting Related Protein Expression in Edited Cells. Liu BY; He XY; Xu C; Xu L; Ai SL; Cheng SX; Zhuo RX Biomacromolecules; 2018 Jul; 19(7):2957-2968. PubMed ID: 29617556 [TBL] [Abstract][Full Text] [Related]
8. Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector. Liu BY; He XY; Zhuo RX; Cheng SX Nanoscale; 2018 Dec; 10(45):21209-21218. PubMed ID: 30417194 [TBL] [Abstract][Full Text] [Related]
9. Fluorinated Acid-Labile Branched Hydroxyl-Rich Nanosystems for Flexible and Robust Delivery of Plasmids. Qi Y; Song H; Xiao H; Cheng G; Yu B; Xu FJ Small; 2018 Oct; 14(42):e1803061. PubMed ID: 30238691 [TBL] [Abstract][Full Text] [Related]
10. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges. Mout R; Ray M; Lee YW; Scaletti F; Rotello VM Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568 [TBL] [Abstract][Full Text] [Related]
11. Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice. Li L; Song L; Liu X; Yang X; Li X; He T; Wang N; Yang S; Yu C; Yin T; Wen Y; He Z; Wei X; Su W; Wu Q; Yao S; Gong C; Wei Y ACS Nano; 2017 Jan; 11(1):95-111. PubMed ID: 28114767 [TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas9-mediated genome editing in apple and grapevine. Osakabe Y; Liang Z; Ren C; Nishitani C; Osakabe K; Wada M; Komori S; Malnoy M; Velasco R; Poli M; Jung MH; Koo OJ; Viola R; Nagamangala Kanchiswamy C Nat Protoc; 2018 Dec; 13(12):2844-2863. PubMed ID: 30390050 [TBL] [Abstract][Full Text] [Related]
13. Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide. Wang HX; Song Z; Lao YH; Xu X; Gong J; Cheng D; Chakraborty S; Park JS; Li M; Huang D; Yin L; Cheng J; Leong KW Proc Natl Acad Sci U S A; 2018 May; 115(19):4903-4908. PubMed ID: 29686087 [TBL] [Abstract][Full Text] [Related]
14. Functionalized PDA/DEX-PEI@HA nanoparticles combined with sleeping-beauty transposons for multistage targeted delivery of CRISPR/Cas9 gene. Ma K; Li W; Zhu G; Sun S; Chi H; Yin Y; Diao H; Xing XJ; Guo Z; Wang L; Xu W; Cui C; Xu J Biomed Pharmacother; 2021 Oct; 142():112061. PubMed ID: 34449313 [TBL] [Abstract][Full Text] [Related]
15. Gene editing in clinical isolates of Candida parapsilosis using CRISPR/Cas9. Lombardi L; Turner SA; Zhao F; Butler G Sci Rep; 2017 Aug; 7(1):8051. PubMed ID: 28808289 [TBL] [Abstract][Full Text] [Related]
16. Self-Assembled Plasmid Delivery System for PPM1D Knockout to Reverse Tumor Malignancy. Ren XH; He XY; Liu BY; Xu C; Cheng SX ACS Appl Bio Mater; 2020 Nov; 3(11):7831-7839. PubMed ID: 35019523 [TBL] [Abstract][Full Text] [Related]
17. Genome editing of mutant KRAS through supramolecular polymer-mediated delivery of Cas9 ribonucleoprotein for colorectal cancer therapy. Wan T; Chen Y; Pan Q; Xu X; Kang Y; Gao X; Huang F; Wu C; Ping Y J Control Release; 2020 Jun; 322():236-247. PubMed ID: 32169537 [TBL] [Abstract][Full Text] [Related]
18. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina. Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510 [TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9 delivery with one single adenoviral vector devoid of all viral genes. Ehrke-Schulz E; Schiwon M; Leitner T; Dávid S; Bergmann T; Liu J; Ehrhardt A Sci Rep; 2017 Dec; 7(1):17113. PubMed ID: 29215041 [TBL] [Abstract][Full Text] [Related]
20. Retroviral Vectors for Cancer Gene Therapy. Schambach A; Morgan M Recent Results Cancer Res; 2016; 209():17-35. PubMed ID: 28101685 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]